Table 2 Study outcomes
Study, Year | Follow Up (months) | PROMs | Revision or Complication | ROM | Radiologic Measures | ||||
|---|---|---|---|---|---|---|---|---|---|
Measure | Results | Measure | Results | Measure | Results | Measures and Method | Results | ||
Ahearn 2021 [11] | 12 | EQD5. KOOS | APD had superior scores for (Mobility, Activity and Anxiety) for EQ5D And KOOS Function | - | - | - | - | - | - |
Kleeman-Forsthuber 2024 [8] | 28 for APD 73 for MDD | - | - | Revisions (no. and cause) CKE and AKP rate | APD: 7 (3 for patella failure) MDD: 3 (no patella failure) APD had more CKE and AKP rates (18 APD/2 MDD) | n-WB ROM | NS | Merchant and lateral views SPPF, LPD, PTA, Insall-Salvati ratio | APD: had greater PTA, and LPD values and SPPF rates |
Mannen 2019 [12] | 9 | KSS, KOOS, PKIP | NS | - | - | WB, n-WB FF | NS | Measured during full ROM ERA and IRA, LPD measured during full ROM | APD had lower ERA |
Mochizuki 2021 [10] | 12 | JKOM | NS | Revisions or Complications | 0 | n-WB ROM | NS | Merchant and lateral and anterior views at 30, 60, 90, 120 degree of knee flexion IRA, PTA | NS |
Shon 2022 [7] | 3, 6, 12 | KOOS, WOMAC, Feller, Kujala | NS | Revisions or Complications | 0 | n-WB FF, FC at 3,6,12 m | APD at 6 m had greater FF | Merchant view PTA, LPD | APD had lower PTA angles |
Sobhi 2024 [5] | 1, 12 | OKS | NS | Reoperations (Revision no.) | APD: 7 (0) MDD: 6 (2 ongoing pain) | n-WB ROM | NS | Merchant and lateral views PTA, RLL, LPD | APD: more RLLs for lateral femur view and greater PTA MDD: more RLLs for axial patella view and greater LPD |
Kim 2023 [9] | 24 | KSS, WOMAC, Kujala, HSS | NS | Revision or Complication | 0 | n-WB ROM, FF, FC | NS | Merchant and lateral views PTA, PTA outliers Blackburne-Peel ratio | NS PTA outliers (APD: 11 and MDD: 5%) |